Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04169152 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CAES for Internal Hemorrhoids and Rectal Prolapse

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Dec 30, 2022 to Dec 30, 2027
    • Study sites: 0 to 1
    • Study completion date: Jun 30, 2023 to Jun 30, 2028
    • Secondary endpoints: 6 to 7
  2. Minor Re-verified, no change to tracked fieldsv3
  3. Notable Primary endpoint revised
    • Secondary endpoints revised (6)
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cap-assisted endoscopic sclerotherapy (CAES) is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. However, the long-term efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse are still not clear due to the lack of large sample studies. Therefore, a nationwide multi-center, large sample, prospective and cohort study was designed to evaluate the efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse, to provide reliable evidence for popularization of this minimally invasive technology.
Trial Details
NCT Number NCT04169152
Lead Sponsor Faming Zhang
Conditions
(from sponsor)
Internal Hemorrhoid, Rectal Prolapse
Related terms Rectal Prolapse
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov